Cargando…

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

INTRODUCTION: OncotypeDX© Recurrence Score (RS) is a multigene panel used to aid therapeutic decision making in early-stage, estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) breast cancer. AIM: To compare responses to neoadjuvant endocrine therapy (NET) in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142274/ https://www.ncbi.nlm.nih.gov/pubmed/34022714 http://dx.doi.org/10.1016/j.breast.2021.04.010

Ejemplares similares

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
por: Davey, M.G., et al.
Publicado: (2021)

Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Using menopause status and 21-gene expression assay to inform chemotherapy benefit in node-positive breast cancer
por: Davey, Matthew G., et al.
Publicado: (2022)

Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
por: Davey, M G, et al.
Publicado: (2021)

Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials
por: Davey, Matthew G., et al.
Publicado: (2022)

Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy
por: Boland, M. R., et al.
Publicado: (2017)

Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022)

Comparing surgical outcomes of approaches to adrenalectomy — a systematic review and network meta-analysis of randomised clinical trials
por: Davey, Matthew G., et al.
Publicado: (2023)

Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2023)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)

Evaluating the Clinical Utility of Routine Sentinel Lymph Node Biopsy and the Value of Adjuvant Chemotherapy in Elderly Patients Diagnosed With Oestrogen Receptor Positive, Clinically Node Negative Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2021)

Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

A radiomic model to classify response to neoadjuvant chemotherapy in breast cancer
por: McAnena, Peter, et al.
Publicado: (2022)

Evaluating the Fragility of Long-Term Outcomes for Neoadjuvant versus Adjuvant Chemotherapy Prescription in Early Breast Cancer: Pooled Data from 10 Randomised Clinical Trials
por: Davey, Matthew G, et al.
Publicado: (2022)

Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023)

Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
por: O'Connor, Dómhnall J., et al.
Publicado: (2021)

Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer: A Prospective, Multicenter Clinical Trial
por: Davey, Matthew G., et al.
Publicado: (2022)

MicroRNA Expression Profiles and Breast Cancer Chemotherapy
por: Davey, Matthew G., et al.
Publicado: (2021)

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
por: Kerin, Eoin P., et al.
Publicado: (2022)

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
por: Goncalves, Rodrigo, et al.
Publicado: (2017)

The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
por: Davey, Matthew G., et al.
Publicado: (2021)

ASO Visual Abstract: Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy
por: Murphy, Brenna M., et al.
Publicado: (2021)

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
por: Chia, Y H, et al.
Publicado: (2010)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020)

MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors
por: Richard, Vinitha, et al.
Publicado: (2021)

A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©
por: Davey, Matthew G., et al.
Publicado: (2022)

Breast cancer recurrence: factors impacting occurrence and survival
por: Courtney, Donald, et al.
Publicado: (2022)

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
por: Ellis, Matthew J., et al.
Publicado: (2008)

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Dysregulated miR-183 inhibits migration in breast cancer cells
por: Lowery, Aoife J, et al.
Publicado: (2010)

Habituation and individual variation in the endocrine stress response in the Trinidadian guppy (Poecilia reticulata)
por: Houslay, T.M., et al.
Publicado: (2019)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
por: Martí, Covadonga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_duat7odu3e0ptqvu9keo74nrl2